Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT02519985
Other study ID # LoVC-005
Secondary ID
Status Suspended
Phase N/A
First received
Last updated
Start date November 1, 2016
Est. completion date December 31, 2025

Study information

Verified date December 2023
Source London Vision Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the repeatability and reproducibility of corneal (including corneal, epithelial, stromal, and LASIK flap thickness) and anterior segment measurements using the ArcScan Insight 100 very high-frequency digital ultrasound arc-scanner.


Description:

Very high-frequency (VHF) digital ultrasound was first used in 1993 to obtain images of the cornea (the window at the front of the eye) and anterior segment (the space behind the cornea including the iris and the lens). A commercially available instrument, called the Artemis 2, has been used in routine clinical practice since 2001. The Artemis 2 was CE approved as well as having FDA approval (the US equivalent of the CE mark). The ArcScan Insight 100 VHF digital ultrasound scanner is a new instrument so does not yet have a CE mark. However, the ArcScan Insight 100 is an upgraded version of the Artemis 2, so any differences are improvements to components, but the measurement method remains essentially the same. The aim of the study is to establish the repeatability (i.e. the variability in measurements taken by a single examiner during a single visit) and reproducibility (i.e. the variability in measurements taken in the same conditions between two examiners) of the ArcScan Insight 100 device for measuring corneal and anterior segment parameters.


Recruitment information / eligibility

Status Suspended
Enrollment 40
Est. completion date December 31, 2025
Est. primary completion date December 31, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years and older
Eligibility INCLUSION CRITERIA Only patients who are medically suitable for corneal refractive surgery can be included in the study. As general inclusion criteria the following aspects are defined: - Subjects should be 21 years of age or older. - Contact lens wearers must stop wearing their contact lenses at least four weeks per decade of wear before baseline measurements in case of hard contact lenses and one week before baseline measurements in case of soft contact lenses. - Patient will be able to understand the patient information and willing to sign an informed consent. For the repeatability and reproducibility phase using normal eyes of the study: - Eyes with no ocular pathology - Eyes with no previous ocular or corneal surgery For the repeatability and reproducibility phase using post-LASIK eyes of the study: • Eyes between 3 and 9 months after LASIK or SMILE For the comparison of ArcScan Insight 100 VHF digital ultrasound with RTVue OCT • Either eyes before or after corneal refractive surgery EXCLUSION CRITERIA - Previous ocular or corneal surgery (for normal eyes) - Patient not being able to tolerate local or topical anesthesia - Patient has active conjunctivitis or any active ocular infection or inflammation - Patient has a corneal ulcer - Patient has an open wound on the corneal epithelium - Patient has compromised epithelium (e.g. =Grade 3 superficial punctate keratitis) - Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ArcScan Insight 100 very high-frequency digital ultrasound
The ArcScan Insight 100 VHF digital ultrasound scanner that can measure individual layers within the cornea with very high precision, as well as being able to image the interior of the eye including the chamber between the iris and the cornea, the lens and other structures behind the iris. The ArcScan Insight 100 device is a digital ultrasound scanner, meaning that it uses ultrasound waves to measure parameters of the eye. The Insight examination involves the patient sitting in front of the ultrasound unit and looking through a disposable goggle-like eyepiece at a light source. Warm sterile balanced saline solution (like natural tears) are used to fill the space between the light source and the eye, to allow ultrasound transmission. There is no contact between the instrument and the eye other than being immersed in this water bath.

Locations

Country Name City State
United Kingdom London Vision Clinic London

Sponsors (2)

Lead Sponsor Collaborator
London Vision Clinic Arcscan, Inc.

Country where clinical trial is conducted

United Kingdom, 

References & Publications (5)

Ogbuehi KC, Osuagwu UL. Repeatability and interobserver reproducibility of Artemis-2 high-frequency ultrasound in determination of human corneal thickness. Clin Ophthalmol. 2012;6:761-9. doi: 10.2147/OPTH.S31690. Epub 2012 May 21. — View Citation

Paul T, Lim M, Starr CE, Lloyd HO, Coleman DJ, Silverman RH. Central corneal thickness measured by the Orbscan II system, contact ultrasound pachymetry, and the Artemis 2 system. J Cataract Refract Surg. 2008 Nov;34(11):1906-12. doi: 10.1016/j.jcrs.2008.07.013. — View Citation

Pinero DP, Plaza AB, Alio JL. Anterior segment biometry with 2 imaging technologies: very-high-frequency ultrasound scanning versus optical coherence tomography. J Cataract Refract Surg. 2008 Jan;34(1):95-102. doi: 10.1016/j.jcrs.2007.08.033. — View Citation

Reinstein DZ, Silverman RH, Raevsky T, Simoni GJ, Lloyd HO, Najafi DJ, Rondeau MJ, Coleman DJ. Arc-scanning very high-frequency digital ultrasound for 3D pachymetric mapping of the corneal epithelium and stroma in laser in situ keratomileusis. J Refract Surg. 2000 Jul-Aug;16(4):414-30. doi: 10.3928/1081-597X-20000701-04. Erratum In: J Refract Surg 2001 Jan-Feb;17(1):4. — View Citation

Ursea R, Feng M, Urs R, RoyChoudhury A, Silverman RH. Comparison of artemis 2 ultrasound and Visante optical coherence tomography corneal thickness profiles. J Refract Surg. 2013 Jan;29(1):36-41. doi: 10.3928/1081597X-20121126-01. Epub 2012 Nov 30. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Repeatability of ArcScan Insight 100 corneal scans in normal eyes (standard deviation) The standard deviation of 5 repeated measurements for corneal thickness, epithelial thickness, and stromal thickness in normal eyes with no previous corneal surgery 1 day
Secondary Reproducibility of ArcScan Insight 100 corneal scans in normal eyes (between-operator standard deviation) The between-operator standard deviation of 5 repeated measurements for each operator for corneal thickness, epithelial thickness, and stromal thickness in normal eyes with no previous corneal surgery 1 day
Secondary Repeatability of ArcScan Insight 100 anterior segment scans in normal eyes (standard deviation) The standard deviation of 5 repeated measurements for anterior segment dimensions: angle diameter, sulcus diameter, anterior chamber depth, and lens rise from the zonular plane in normal eyes with no previous corneal surgery 1 day
Secondary Reproducibility of ArcScan Insight 100 anterior segment scans in normal eyes (between-operator standard deviation) The between-operator standard deviation of 5 repeated measurements for each operator for anterior segment dimensions: angle diameter, sulcus diameter, anterior chamber depth, and lens rise from the zonular plane in normal eyes with no previous corneal surgery 1 day
Secondary Repeatability of ArcScan Insight 100 corneal scans in eyes after corneal laser refractive surgery (standard deviation) The standard deviation of 5 repeated measurements for corneal thickness, epithelial thickness, stromal thickness, flap thickness, and residual stromal thickness in eyes after corneal laser refractive surgery 1 day
Secondary Reproducibility of ArcScan Insight 100 corneal scans in eyes after corneal laser refractive surgery (between-operator standard deviation) The between-operator standard deviation of 5 repeated measurements for each operator for corneal thickness, epithelial thickness, stromal thickness, flap thickness, and residual stromal thickness in eyes after corneal laser refractive surgery 1 day
See also
  Status Clinical Trial Phase
Suspended NCT03473847 - Repeatability, Reproducibility and Comparison of Cirrus OCT, RTVue OCT, MS-39 OCT, and Insight 100 VHFDU N/A